---
title: "Hangzhou Tigermed files HKEX next-day disclosure return on share repurchase"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290167559.md"
description: "Hangzhou Tigermed filed an HKEX disclosure reporting the repurchase of 542,400 A-shares on June 18, 2026. The shares were bought on the Shenzhen Stock Exchange at prices ranging from RMB 39.33 to RMB 39.98 per share, with a total aggregate price of RMB 21.62 million. These shares are held as treasury shares and have not been cancelled."
datetime: "2026-06-18T08:50:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290167559.md)
  - [en](https://longbridge.com/en/news/290167559.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290167559.md)
generator: "portal-rs"
---

# Hangzhou Tigermed files HKEX next-day disclosure return on share repurchase

-   Hangzhou Tigermed filed an HKEX next-day disclosure return reporting a repurchase of 542,400 A shares on June 18, 2026. \* Shares were bought on the Shenzhen Stock Exchange at RMB 39.33 to RMB 39.98 per share; aggregate price paid RMB 21.62 million. \* Total repurchased shares: 542,400; held as treasury shares, not cancelled. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hangzhou Tigermed Consulting Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260618-12207746), on June 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [03347.HK](https://longbridge.com/en/quote/03347.HK.md)
- [300347.CN](https://longbridge.com/en/quote/300347.CN.md)

## Related News & Research

- [Tigermed Directors Face Regulatory Warning and Fines Over Disclosure Lapses](https://longbridge.com/en/news/298755822.md)
- [Tigermed says China regulator plans CNY 1 million fine for controllers over disclosure breaches](https://longbridge.com/en/news/298735049.md)
- [Citi: TIGERMED Regulatory Uncertainty Removed; Buy Rating and Top Pick Status Reiterated](https://longbridge.com/en/news/298863213.md)
- [Hangzhou Tigermed announces 2026 interim results presentation availability](https://longbridge.com/en/news/297293955.md)
- [Hangzhou Tigermed amends rules governing management of controlling subsidiaries](https://longbridge.com/en/news/297331443.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**